These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7698870)

  • 1. Remission of secondary Raynaud phenomenon using intra-arterial prostaglandin E1 infusion. A case report.
    Seemann J; Scholz J; Sielwicz M
    Int Orthop; 1994; 18(6):372-4. PubMed ID: 7698870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon.
    DiGiovanni RL; Littlefield JM; Good RG
    J Am Osteopath Assoc; 1995 Oct; 95(10):572. PubMed ID: 8557544
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of refractory ischemic skin ulcers in patients with Raynaud's phenomenon with PGE1 infusions.
    Langevitz P; Buskila D; Lee P; Urowitz MB
    J Rheumatol; 1989 Nov; 16(11):1433-5. PubMed ID: 2600942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T; Eckstein H; Weiss C; Diehm C
    Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud's phenomenon.
    Bartolone S; Trifiletti A; De Nuzzo G; Scamardi R; Larosa D; Sottilotta G; Raffa A; Barbera N
    Minerva Cardioangiol; 1999 May; 47(5):137-43. PubMed ID: 10479851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with the therapy of acute finger ischemia by high-dose intra-arterial infusion of PGE1 through a surgically introduced catheter].
    Altstaedt HO
    Chirurg; 1999 Oct; 70(10):1144-8. PubMed ID: 10550345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atypical HHS-syndrome--a rare differential diagnosis of circulatory disorders of the hand].
    Müller-Mai C; Voigt C; Smektala R; König M
    Handchir Mikrochir Plast Chir; 2004 Feb; 36(1):59-63. PubMed ID: 15083393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of hepatic arterial infusion of prostaglandin E1 in the treatment of postoperative acute liver failure--report of a case.
    Sato T; Asanuma Y; Hashimoto M; Heianna J; Kusano T; Kurokawa T; Yasui O; Koyama K
    Hepatogastroenterology; 2000; 47(33):846-50. PubMed ID: 10919045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin infusion therapy for intermittent digital ischemia in a patient with mixed connective tissue disease. Case report and review of the literature.
    Cohen LE; Faske I; Fenske NA; Greist MA
    J Am Acad Dermatol; 1989 May; 20(5 Pt 2):893-7. PubMed ID: 2654223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Critical ischemia of the extremities caused by ergotism. Treatment with intra-arterial prostaglandin E1 infusion].
    Horstmann R; Daum H; Heller M; Schröder A
    Dtsch Med Wochenschr; 1993 Jul; 118(29-30):1067-71. PubMed ID: 8330508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raynaud's disease in childhood with radiological features.
    Shono T; Okadome K; Naritomi G; Suita S
    Br J Radiol; 1990 May; 63(749):364-6. PubMed ID: 2379063
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
    Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
    Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of Raynaud's phenomenon with limaprost, an oral prostaglandin E1 analogue.
    Tsukamoto H; Nagasawa K
    Br J Rheumatol; 1991 Aug; 30(4):317. PubMed ID: 1863837
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin E1 in severe Raynaud's phenomenon.
    Pardy BJ; Hoare MC; Eastcott HH; Miles CC; Needham TN; Harbourne T; Ellis BW
    Surgery; 1982 Dec; 92(6):953-65. PubMed ID: 6890719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of vasospastic disease with prostaglandin E1.
    Clifford PC; Martin MF; Sheddon EJ; Kirby JD; Baird RN; Dieppe PA
    Br Med J; 1980 Oct; 281(6247):1031-4. PubMed ID: 7427564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new peripheral vasodilator prostaglandin E1 in atherosclerosis of lower limb vessels and Raynaud disease].
    Kirichenko AA; Novichkova IuN; Zubkova LV; Ter-Gevondian NM; Nenakhova TV
    Klin Med (Mosk); 1991 Nov; 69(11):40-3. PubMed ID: 1808404
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome.
    Lucas GS; Simms MH; Caldwell NM; Alexander SJ; Stuart J
    J Clin Pathol; 1984 Aug; 37(8):870-3. PubMed ID: 6540787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary results of prostaglandin E1 therapy in peripheral obliterating arteriopathy].
    Pilger E; Juan H
    Wien Klin Wochenschr; 1983 Apr; 95(8):263-6. PubMed ID: 6683910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Duplex ultrasound measurement of hemodynamic parameters at rest and following arterial stenosis: effect of intra-arterial infusion therapy with prostaglandin E1].
    Ranke C; Creutzig A; Alexander K
    Vasa Suppl; 1989; 27():353-5. PubMed ID: 2696104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.